The relationship has been studied (1) between the stimulation by antigen of the rate of deoxyribonucleic acid (DNA) synthesis and cell division, and the production of specific hemolytic antibody-synthesizing cells in suspensions of cells from the spleens of rabbits undergoing a secondary response to sheep red blood cells (SRC's). The results, using the specific hemolytic plaque technique, indicated that the majority of antibody-producing cells arose from the DNA-synthesizing population but that only a small proportion of all these cells, dividing in vitro in response to specific antigen, actually produced antibody to SRC's under the conditions of the experiments. The present paper reports the effects of actinomycin D and puromycin on such cells in vitro.
The mode of action of actinomycin D has been well established (2, 3) . This antibiotic has been shown to block ribonucleic acid (RNA) synthesis by binding to the deoxyguanosine residues of DNA in a selective manner, with resulting interference with the formation of RNA polymerase as the primary effect. Suppression of the incorporation of uridine and cytidine into nucleolar RNA has been shown (4) to be the earliest effect of low concentrations of this inhibitor on mammalian ceils in tissue culture. More recent reports (5) have suggested that there may be other effects of this agent on cells, such as glucose deprivation, resulting in reduced protein synthesis.
Antibody synthesis in vitro is inhibited by actiuomycin D (6-8) but its effect on antibody responses in intact animals has been found to be more variable. This antibiotic partially inhibited the primary response to SRC's in mice (9) , while another study (10) , using actinomycin C, failed to suppress the antibody response of rabbit spleen cells transferred into newborn rabbits. In another report (11) , actinomycin D delayed the appearance of antibody in the serum of rats undergoing a primary response, but there was no apparent effect on total circulating antibody production, while persistence of secondary antibody production in the presence of toxic doses of this inhibitor in mice has been described (12) . An interesting study (13) has reported the conversion of the tolerogenic stimulus of soluble bovine gamma globulin into an immunogenic one by actinomycin D. Investigations of other types of protein synthesis in intact animals have shown that actinomycin D could induce the production of adaptive enzymes in rat liver (14) while both actinomycin D and puromycin accelerated the increase of alkaline phosphatase activity in the duodenum of young mice (15) . 675
In vitro studies using actinomycin D have shown both inhibition (16) as well as stimulation (17) of protein synthesis in cells of mammalian origin. Puromycin inhibits protein synthesis in cell-free systems (18) as well as whole cells (19) , and differences between its mode of action in vivo and in vitro have been reported (20) . Studies of the structural requirements for its inhibitory effects on protein synthesis (21) have suggested that this antibiotic binds to the active center of an enzyme or RNA protein involved in the final steps of protein synthesis. Antibody synthesis by rabbit lymph node cells (6) and mouse spleen cells (22) in vitro was inhibited by puromycin in the same way as were other types of protein synthesis.
Materials and Methods
Immunization of rabbits, preparation and culture of spleen cell suspensions, estimation of antibody-producing cells (PFC's), and radioautographic techniques have been described in Spleen cell suspensions from a rabbit killed 3 days after a boost of SRC's were incubated at 10 7 cells/culture containing 5 X 10 6 SRC's in the presence or absence of actinomycin D. The numbers of PFC's were assayed at the times shown. The volume of medium used for individual cultures in this and all subsequent experiments was 1.5 ml.
detail (23, 1) . Actinomycin D was a generous gift from Merck, Sharp and Dohme, Rahway, N. J., and puromycin was purchased from Nutritional Biochemicals Corporation, Cleveland, Ohio. Both antibiotics were stored under refrigeration in the dark and either made up in solution immediately before use or used within 3 wk of preparation.
IsotopicallyLabded Matzr/a/s--Thymidine-14C at 30.4 mc/m~r; thymidine-3H at 2.16 c/ mM, used at 300 mc/m~,; uridineA4C at 32 me/m~,; uridine-aH at 2.18 c/ram; leucine-14C at 32 mc/m~,; and leucine-SH at 18.3 c/nm were obtained from the Radioehemical Centre, Amersham, England. Methods of measurement of uptake of 3H-labeled (24, 25) and 14C-labeled materials (23) have been fully described. 14C-labeled precursors were used for radioautography of PFC's by the methods detailed elsewhere (1) .
RESULTS
The acute effect of actinomycin D on PFC's is seen in Table I . Low concentrations of the inhibitor in the medium had no appreciable effect on the numbers of PFC's from the spleen of a rabbit killed 2 days after an intravenous boost of SRC's, while a high concentration depressed the numbers of PFC's after 3 hr incubation. The results of a typical experiment shown in Table II indicate that the rate of RNA synthesis, measured by the incorporation of uridine-SH, was inhibited after 30 rain incubation of rabbit spleen cells with a high concentration of actinomycin D. Assay of PFC's in identical cultures showed that antibody production was not affected until after several hours exposure to the inhibitor, maximal reduction of PFC's requiring 6 hr of contact with actinomycin D.
The long-term effects of high concentrations of actinomycin D on PFC's in spleen cell suspension from boosted rabbits are shown in Table IH . Spleen ceils from rabbits killed 3 or 2 days after boosting with SRC's were exposed to actinomycin D, added to cultures initially. After a marked suppression of PFC's Spleen cell suspensions from a rabbit killed 2 days after a boost injection of SRC's were incubated with 5 X 106 SRC's/culture (SRC) or in the presence of actinomycin D 10/~g/ culture as well as SRC's (SRC + Act.D). The numbers of PFC's and the incorporation of uridine-3H, 2 ~tc/culture, which was added initially, were estimated at the times indicated.
during the first 2 days of culture, a recovery of the ability of the cell suspensions to produce PFC's was seen. The recovery of numbers of PFC's was always best in cultures of spleen cells from rabbits killed 3 days after boosting, and increases well above the numbers of PFC's in cultures which had never been exposed to actinomycin D frequently occurred. In many experiments with spleen cells from rabbits boosted 2 days before killlug, any recovery of hemolytic plaque-forming ability by cells, after initial suppression by actinomycin D, was much lower than with cells from rabbits boosted 3 days before. As seen in Table  III , no recovery might be seen in suspensions of spleen cells from rabbits killed after a boost 2 days before, but PFC's were never completely suppressed by high concentrations of actinomycin D. Experimental results, not shown here, indicated that spleen cells from rabbits boosted with SRC's 2 or 3 days before killing and incubated with actinomycin D, but in the absence of specific antigen in the medium, showed little or no recovery of P F C ' s in vitro. Therefore, the presence of specific antigen in the culture medium was necessary for this apparent stimulatory effect of high concentrations of actinomycin D on PFC's, after initial suppression. Spleen cells from nonboosted and nonimmunized rabbits were never stimulated by actinomycin D in this way. Spleen cell suspensions from rabbits killed either 2 days or 3 days after a boost injection of SRC's were cultured in the presence of 5 X 106 SRC/culture and actinomycin D was added initially. The number of PFC's was estimated dally, and was calculated as the proportion of ceils initially set up in cultures in this and all subsequent tables. I n view of this interesting and unexpected observation, further experiments involving the addition of acfinomycin D to suspensions of rabbit spleen cells at different times were carried out. Removal of actinomycin D from cultures b y washing the cells three times in medium and then reincubating in inhibitor-free medium did not show any reversal of the effects of the antibiotic after it had been in contact with the cells for at least 4 hr. When more actinomycin D was added to cells which had been exposed initially to the antibiotic and after recovery of the numbers of P F C ' s had occurred, no further inhibition of P F C ' s was seen.
The results in Table IV show the typical effect of adding a high concentration of actinomycin D to spleen cell suspensions from a rabbit killed 2 days after a boost of SRC's. When added initially, the actinomycin D inhibited the PFC's in cultures incubated in the presence or absence of SRC's, but a small number of active PFC's persisted in both types of cultures. Addition of actinomycin D on various days of culture, in the same concentration as suppressed PFC's when added to cultures initially, progressively stimulated an increase in the number of Spleen cell suspensions from a rabbit killed 2 days after a boost injection of SRC's were incubated in the absence (C) or presence (SRC) of the antigen. Actinomycin D, 10/~g/culture, was added at the times shown and the numbers of PFC's estimated on the days of culture indicated.
PFC's only in spleen cell suspensions incubated with SRC's. The maximal stimulation was seen on day 4 of culture when actinomycin D had been added on day 3. Although no enhancement of PFC's was seen in cultures incubated without SRC's, the surviving antibody-producing cells were resistant to actinomycin D. While these results were completely typical, other similar experiments showed some variation of the time of addition of actinomycin D which produced maximal enhancement of PFC's, this time varying from day 2 to day 4 of culture. The stimulating effect on PFC's of actinomycin D added to cultures in this way always increased the number of antibody-producing cells above the levels found in cultures incubated in the presence of SRC's alone. Another variable feature was the time in culture, after adding actinomycin D, that enhancement of PFC's persisted. In some experiments, as shown in Table V , increase of PFC's was maintained in this way for several days while, in others, there was a rapid fall in the number of PFC's 24-48 hr after the initial increase. Spleen cell suspensions from a rabbit killed 3 days after a boost of SRC's were incubated in medium alone ((2) or with 5 X 106 SRC's/culture (SRC). Actinomycin D, 10 gg/culture, was added initially (SRC + Act.D) or on day 3 or day 4 to cultures exposed initially to SRC's and the number of PFC's estimated daily. Actinomycin D was added on day 3 of culture to spleen cell suspensions from a rabbit killed 2 days after a boost injection of SRC's. The number of PFC's were counted 24 hr after adding the actinomycin D to the cultures, which were incubated with SRC's, added initially.
TABLE VI

The Effect on PFC's of Actinom
The optimal concentration of actinomycin D which stimulated the appearance of specific PFC's in vitro was much higher than the level of the antibiotic required, in cultures of spleen cells from recently killed rabbits, to inhibit DNA, RNA, and protein synthesis. As shown in Table VI , a concentration of 100 ~g/ culture was still highly sdmulatory. In addition, the results in Table VII indicate that the response of PFC's to actinomycin D, enhancing their numbers, was time-dependent, reaching a maximal level after 4 hr exposfire to the antibiotic.
The effect of actinomycin D on the incorporation of thymidine, uridine, and leucine was studied in spleen cell suspensions from immunized rabbits. As shown in Table VIH , actinomycin D inhibited incorporation of thymidine and uridine when added initially to cultures, uridine uptake being depressed much earlier and to a greater degree than the incorporation of thymidine. Spleen cell suspensions from a rabbit killed 2 days after a boost of SRC's were cultured in the presence of 5 X 10 s SRC/culture. Actinomycin D, at 10/~g/culture, was added (SRC -IAct.D) on day 3, and the numbers of PFC's were estimated at the times shown. 
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Spleen cell suspensions from a rabbit boosted with antigen 2 days before killing were incubated in actinomycin D as shown. The uptakes of thymidine-3H and uridine-SH, both at 2 /zc/culture, were estimated for 1 hr periods between 0 and 4 hr of incubation, and the amounts incorporated were calculated as per cent of identical control cultures, incubated without any actinomycin D.
The experiment reported in Table IX indicates that the addition of actinomycin D to cultures initially inhibited the rate of DNA synthesis, as measured by the incorporation of thymidine, during the 24-48 hr period of culture. In this period, maximal differences were seen between control cultures incubated in medium alone and identical cultures incubated in the presence of a stimulant to cell proliferation, such as the specific antigen or phytohemagglutinin (PHA). Spleen ceils which were responding to antigen or PHA appeared more sensitive to the inhibitory effect of actinomycin D on thymidine incorporation than did control cells.
Actinomycin D had a profoundly depressive effect on uridine incorporation during the first 24 hr period of culture of rabbit spleen cell suspensions when the rate of R N A synthesis was most active (Table X) . Incorporation of uridine was never completely suppressed by actinomycin D during this period of culture.
As seen in these results, incorporation of uridine fell to low levels after this initial active period, even in cultures not exposed to inhibition, and this can be Spleen cell suspensions from a rabbit killed 2 days after a boost of SRC's were incubated in medium alone (C), SRC's at 5 X 106/culture SRC, or Bacto-phytohemagglutinin P (PHA, Difco Laboratories, Inc., Detroit, Mich.) at 10 #g/culture. Different concentrations of actinomycin D were added initially and thymidine-14C uptake, 0.2 jzc/culture was estimated during 24-48 hr of incubation and calculated as the per cent of identical cultures, incubated without actinomycin D. Spleen cell suspensions from a boosted rabbit were incubated in medium alone (C) with 5 X 106 SRC's/culture (SRC). Actinomyein D was added initially to cultures as indicated. All cultures were washed by centrifugation two times in medium on day 2 of culture, and incubation was continued in inhibitor-free medium, no further antigen being added. correlated with increased cell death and fewer cells labeled on radioautography (personal observations). The significance of this low level of incorporation requires further study by more detailed methods since the amount of labeled precursor incorporated by cells in noninhibited cultures was virtually the same as in cultures exposed to actinomycin D which had been added initially. When actinomycin D was added on day 3 of culture, for the first time, no further inhibition of these low levels of incorporation of uridine was seen.
The results of a typical experiment to show the effect of a high concentration of actinomycin D on the incorporation of leucine-aH by spleen from immunized Spleen cell suspensions from a rabbit boosted 2 days before killing, with human serum albumin (HSA) obtained as a gift from the Lister Institute of Preventive Medicine, London, were incubated in medium alone (C) or with antigen at 1 mg/culture (HSA). Actinomycin D was added initially at 10 #g/culture (HSA -4-Act.D) or on day 3 of culture at the same concentration. Cultures were washed, and incubation was continued in leucine-free medium to measure the uptake of leucine-SH, 5 btg/culture, for 1 hr and 24 hr pulses, on the days of ctflture indicated. rabbits are shown in Table XI . Like the incorporation of uridine-3H, leucine-3H uptake was initially high in these cultures and was depressed by actinomycin D in high concentration, but inhibition was never completely achieved, even with doses higher than were used here. Leucine-3H uptake fell rapidly to low levels with time in culture and this fall of incorporation of leucine-~H was related to cell death and fall in numbers of labeled cells on radioautography (personal observations). When actinomycin D was added to cultures on day 3, there was still some inhibition of leucine uptake but this was not completely suppressed.
Similar experiments have been carried out using puromycin to inhibit leucine incorporation in these rabbit spleen cell suspensions. Preliminary observations showed that puromycin at 50 #g/culture achieved maximum inhibition. The results of Table XII correlated the effects of this concentration of puromycin on leucine incorporation and the number of PFC's in spleen cell suspensions from a * Nos. in parentheses represent per cent of controls. Spleen cell suspensions from a rabbit boosted with SRC's 3 days before k~l]~ng were incubated in the presence of puromycin, 50 #g/culture. The incorporation of leucine-SH, 5 #c/culture, was measured for 1 hr periods during the first 4 hr of culture and the numbers of PFC's estimated at the times shown. Results were calculated as per cent of similar control cultures incubated without puromycin. days after a boost injection of SRC's were incubated in the presence of 5 X 106 SRC's/culture and actinomycin D or puromycin were added to cultures in the concentrations and at the times shown. The cultures were incubated in uridine-x4C, 0.5 #c/culture or leucine-14C, 0.5 #c/culture for 4 hrs before plating, and the number of PFC's and per cent of labeled PFC's estimated by radioautography of the antibody-producing cells. rabbit killed 3 days after a boost of SRC's. In contrast to the effects of actinomycin D, there was a prompt, profound inhibition of leucine uptake as well as reduction in the number of PFC's which was sustained over a period of 24 hr.
TABLE XIII
The Effect of Inhibitors on Individual PFC's
It has been shown (1) that, in spleen cell suspensions from rabbits undergoing a secondary response to SRC's only a small proportion of cells responding to antigen in vitro by an enhanced rate of DNA synthesis and cell division actually became PFC's, and that they accounted for virtually all the PFC's developing in these cultures. It was therefore important to attempt direct observation on the individual cell releasing antibodies to the SRC's. Results of experiments which have correlated the effects of actinomycin D and puromycin on the number of PFC's with radioautography of these cells are shown in Table XIII . The incorporation of both urldine-14C and leucine-14C into individual PFC's falls with time in culture in the presence of SRC's but in the absence of inhibitors. Actinomycin D, added on day 2 or day 3 of culture, enhanced the number of PFC's but completely inhibited the incorporation of uridine-l*C into individual PFC's. While a few cells appeared to be labeled with leucine-14C after contact with actinomycin D, the degree of labeling was very light compared with slmilar cells not exposed to the antibiotic. The majority of cells showed no label above background in these preparations. Puromycin produced very similar effects to actinomycin D, with marked enhancement of the number of PFC's compared to cultures not exposed to the antibiotic. In the same way, the vast majority of these PFC's did not show any evidence of labeling with leucine-14C on radioantography.
DISCUSSION
Acute Effects of Inhibitors.--Actinomycin D, added to spleen cell suspensions immediately after isolation from rabbits killed after boosting with SRC's, produced marked suppression of the numbers of PFC's. This inhibition of antibodyproducing ceils by high doses of actinomycin D only occurred after suppression of RNA synthesis as measured by the incorporation of uridine-SH had been achieved. This agent has been shown to have a highly selective action, inhibiting DNA-dependent RNA synthesis (2) . Low doses of actinomycin D in vitro have been found to inhibit nucleolar RNA synthesis but to permit continued synthesis of RNA with a DNA-like base composition (3), while high doses of 1-5 /zg/ml in cultures have been shown to inhibit 95 % of total RNA synthesis in animal cells (26) . High concentrations of actinomycin D were used in the present experiments and, while the exact nature of the RNA's suppressed in the mixed populations present in rabbit spleen cell suspensions would be difficult to evaluate, total RNA synthesis was profoundly depressed by this agent. If antibody synthesis in these cultures was dependent on messenger RNA, and if inhibition of messenger RNA were responsible for cessation of antibody synthesis (5), it would appear that this template RNA, in antibody-forming cells from spleen cell suspensions from boosted rabbits, had a finite stability since there was a lapse of about 2 hr between suppression of uridine incorporation by actinomycin D and reduction in numbers of PFC's. This conclusion would agree with the results of studies (6) using the incorporation of labeled amino acids into antibody protein by lymph node cells from immunized rabbits, and further indicates that specific hemolytic plaque formation by recently isolated ceUs from the spleens of rabbits, killed after a boost of SRC's, was dependent on the normal processes of protein synthesis. The acute effects of inhibitory concentrations of puromycin on such cells would confirm this. This antibiotic suppresses protein synthesis (18) (19) (20) (21) (22) , and in the present experiments inhibition of PFC's in recently isolated spleen cell suspensions from boosted rabbits could be correlated with the inhibition of the incorporation of leucine-~I-I by all the cells in these suspensions.
Long-Term Effects of Inhibitors.--The long-term effects of actinomycin D and
puromycin in vitro on the number of PFC's present in suspensions of spleen ceils from rabbits killed 3 days after boosting with SRC's was unexpected. The presence of SRC's in the culture medium was essential for recovery in the number of PFC's to occur after inhibition by actinomycin D or puromycin added initially to the cultures. This recovery pattern was typically greater and more constant in suspensions of spleen cells taken from rabbits 3 days after boosting with antigen than in similar suspensions from rabbits boosted 2 days before killing These observations indicate that there were differences in the populations of antibody-producing ceils in the spleens from rabbits boosted 3 days before killing compared to similar populations from animals boosted 2 days before killing. The results presented here show that high concentrations of actinomycin D could rapidly suppress both RNA and DNA synthesis rates when added initially to these spleen cell suspensions and that this effect was sustained; but the presence of antigen, added initially to the cultures, was still able to induce the appearance of PFC's by day 3 of culture despite the presence of the inhibitor. (It should be noted that an exactly similar recovery of PFC's exposed to puromycin, added initially to cultures, also occurred). The intravenous injection of SRC's into the rabbits before killing them for these experiments had already triggered a proliferative responsive population of ceils in their spleens. It has been shown (23) that many of the dividing cells can be stimulated to further divison by antigen in vitro, and that the PFC's which developed in vitro were derived from this population of DNA-synthesizing ceils (1) . If all messenger RNA synthesis was interrupted by actinomycin D, added initially to these cultures, and if hemolytic-plaque formation was still dependent on protein synthesis continuing in the presence of this agent, then the existence of a highly stable messenger RNA necessary for the synthesis of the antibody molecule must be postulated. A more remote possibility would be that the production of messenger RNA for specific antibody synthesis continued in the presence of inhibitor. Another point to be considered was whether ceils present in the spleens of rabbits killed 3 days after boosting had already been induced to prepare for specific antibody synthesis before exposure to antigen in vitro. Since actinomycin D, in high concentration, completely prevented the proliferative response of cells to antigen in vitro, and since it has been shown (1) that this response was necessary for the maintenance of PFC's in vitro, antigen must be acting, in some way, on cells which had been committed in vivo to synthesize specific antibody even though they were under the inhibitory effects of actinomycin D. If the PFC's present in rabbit spleen cell suspensions 3 days after exposure, in vitro, to high concentrations of actinomycin D or puromycin were the result of an in vitro response to antigen requiring DNA and RNA synthesis by PFC's, then antigen would have had to act very quickly before inhibition by these agents had occurred. This is unlikely since the proliferative response of cells to antigen added initially, in these cultures, was never seen until long after maximum suppression by these inhibitors would have occurred. Other experiments, not reported here, have shown that when actinomycin D or puromycin was added initially to cultures several hours before antigen, which was added after maximum suppression by these inhibitors had been achieved, recovery of PFC's still occurred by d~ys 3-4 of culture.
The Effect of Delay in Addition of Inhibitors to Cultures.--When actinomycin
D or puromycin was added to suspensions of spleen cells from boosted rabbits at various times in culture, not only was there an increasing resistance of the surviving PFC's in control cultures, incubated without SRC's, but increases in the numbers of PFC's occurred only in cultures incubated with SRC's. This stimulating effect was only seen in spleen cell suspensions from rabbits boosted with SRC's and was never found with nonhoosted and nonlmmunized controls, or with rabbits immunized to other antigens. High concentrations of the inhibitors were required for this stimulating effect which was best seen after 48 hr exposure to antigen in vitro. PFC's in spleen cell suspensions from rabbits, boosted 2 days before killing, were stimulated in this way in contrast to the lack of stimulation in many such cultures by inhibitors added initially. These results suggest that the PFC's, releasing specific antibody in the presence of actinomycin D or puromycin added after an adequate period of contact with antigen, had developed, in response to antigen in vitro, as the result of proliferation and differentiation into antibody-synthesizing cells (PFC's). When the time required for high concentrations of actinomycin D to produce an increase of PFC's was studied, it was found that this corresponded very well to the time taken for suppression of PFC's by actinomycin D added, in the same concentration, to freshly isolated ceils from the spleens of boosted rabbits. If both actinomycin D and puromycin were simply acting as nonspecific toxic agents to injure cells so that they passively released antibody during the plating procedure used to assay PFC's, it would be most unlikely that the level of PFC's would be sustained in the cultures for very long, and it would be impossible to account for the
patterns of depression and recovery in numbers of PFC's seen in cultures exposed initially to these agents. In addition, it would be difficult to understand how the presence of antigen in vitro could affect dead or such severely injured cells. It is therefore concluded that these results demonstrated some form of stimulation of antibody-producing cells as the result of the effects of these inhibitors. Another point to be considered is that these PFC's were inhibited by exposure to high concentrations of oxygen during plating (1), suggesting that plaque-forming ability required active processes for release of antibody.
Effect of InMbitors on Incorporation of Precursors.--Incorporation of pre-
cursors to measure the synthesis rates of DNA, RNA, and protein by these spleen cell suspensions indicated that marked inhibition resulted from the action of these inhibitors added initially. The most detailed results presented here show that actinomycin D, added initially in high concentration, was an effective inhibitor of all synthetic functions. The incorporation rates of precursors fell to low levels after 2 days in vitro even in the absence of inhibitors in the culture medium. This was associated with reduction in the proportions of labeled ceils on radioautography to virtually zero levels by day 4 of culture and by increasing cell death as shown by staining of > 95 % of cells with trypan blue at this time (personal observations). Therefore, these results must be interpreted with some caution in view of marked changes in precursor pools which would have occurred with time in culture. However, in other experiments, increases of the amounts of labeled precursors added to the cultures, as well as changing the culture medium, did not significantly alter the incorporation rates of these precursors. More detailed studies will be required to establish the significance of the low level of labeled materials incorporated into the TCA-precipitable cell material at this time. If incorporation of precursors, measured after day 3 in vitro, indicated true synthesis of RNA and protein, then these processes would appear to be highly resistant to the effect of actinomycin D in high concentration.
Radioautography of PFC's.--In view of these problems, and the fact that only a small proportion of cells were PFC's in these cultures, radioautography of individual cells forming hemolytic plaques after incubation with leucine-14C or uridine-l*C was carried out. The results show that the vast majority of PFC's producing antibody in the presence of actinomycin D or puromycin were not labeling with uridine-14C or leucineJ4C in the ease of the former inhibitor, or with leucine-14C in the case of the latter, indicating that plaque formation in these cells was not dependent on the normal processes of protein synthesis as had been observed in PFC's from the spleens of recently killed rabbits during the first 24 hr in vitro. In addition, it was found that PFC's surviving in cultures of spleen cells from boosted rabbits not exposed to inhibitors, showed a progressive fall, with time in culture, of the numbers of PFC's labeling with uridinet4C or leucine-14C. Since these results indicate that the antibody released by PFC's in the presence of actinomycin D and puromycin might be preformed it would be of interest to investigate whether these ceils contained complete antibody molecules in an intracellular pool or possessed completed light and heavy chains which had not yet been assembled into whole molecules before exposure to inhibitors. If the antibody molecules were completed, they must have been released from the ribosomes on which the polypeptide chains had been synthesized since evidence with IgG molecules (27) and hemoglobin molecules (28) has suggested that polypeptide chains are synthesized on different polysomes. Puromycin has been shown to produce release of incomplete polypeptide chains from the isolated ribosomes of rabbit reticulocytes (29, 30) and it was therefore a possibility that puromycin, in the present experiments, could promote release of light chains from the ribosomes of potential PFC's which could in turn control the release of heavy chains from their separate polysomes, as has been suggested in studies of an ascitic form of murine plasmacytoma (31) and hemoglobin synthesis (28) . This possibility will require further exploration by studies of preparation of ribosomes from rabbit spleen cells after culture in vitro. Although no definite statement can be made at present, results of exposing spleen cells from boosted rabbits to both inhibitors simultaneously in vitro show a lack of summative effects on the number of PFC's, thus suggesting that the same cells were affected by these inhibitors. This would indicate some common mode of response by PFC's in these cultures to two agents with differing modes of action. It would be possible to invoke an inhibitory effect by a repressor gene whose product would depend on both RNA and protein synthesis for its synthesis. A model such as the "blocked" ribosome (32) might be envisaged. Thus inhibition of the synthesis of the product of the repressor gene by actinomycin D or puromycin would allow translation to be completed. Under these circumstances antigen, or its product, might be acting as an inducer, aiding release of the polypeptide chains.
SU~rCrAI~Y
The effects of actinomycin D and puromycin on spleen cell suspensions from rabbits jrnrmmized to SRC's were studied. These inhibitors, in high concentration, suppressed PFC's when added initially to recently isolated cells. When such cells were incubated for several days in the presence of both antigen and inhibitor, both actinomycin D and puromycin produced an increase in PFC's after the initial suppression. This recovery effect was best seen with cells from rabbits killed 3 days after boosting with SRC's, and was usually absent when cells were taken from rabbits killed 2 days after boosting. When actinomycin D or puromycin was added after several days in culture in the presence of SRC's, surviving PFC's were found to be not only resistant to these inhibitors, but there was also an increased number of PFC's compared to similar cultures incubated without these agents.
Radioautographic studies showed that PFC's stimulated by the presence of actinomycin D or puromycin were not incorporating precursors for RNA or protein synthesis. In view of the known mode of action of these inhibitors, it was postulated that they were stimulating antibody production by PFC's in vitro either by interfering with represser mechanisms or stimulating the completion of antibody molecules, perhaps by causing the release of preformed antibody chains from ribosomes.
Since the presence of specific antigens in vitro were necessary for these observed stimulatory effects on PFC's, and since antigens were producing an effect on antibody production on cells which were being suppressed by these inhibitors, added initially, it was further suggested that one role of antigen in the immune response was concemea with the completion of antibody synthesis on the ribosomes, perhaps by acting as an inducer as has been suggested previously (1).
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